Skip to main content
Sanofi India Ltd logo

Sanofi India Ltd — Investor Relations & Filings

Ticker · SANOFI ISIN · INE058A01010 LEI · 335800VFWLEY5V6PYH80 BSE.NS Manufacturing
Open in API
Filings indexed 1,552 across all filing types
Latest filing 2025-11-18 Declaration of Voting R…
Country IN India
Listing BSE.NS SANOFI

About Sanofi India Ltd

https://www.sanofi.in

Sanofi India Ltd focuses on the development, manufacturing, and marketing of a wide range of pharmaceutical products and healthcare solutions. The company operates across several therapeutic areas, including diabetes, cardiology, thrombosis, central nervous system disorders, and consumer healthcare. Its product portfolio includes established brands such as Lantus, Allegra, Combiflam, Amaryl, Avil, and Enterogermina. The organization prioritizes chronic disease management and acute care through a combination of prescription medicines and over-the-counter treatments. By integrating global research capabilities with local manufacturing excellence, the company provides specialized medical solutions aimed at improving patient health outcomes and addressing unmet medical needs.

Recent filings

Filing Released Lang Actions
Please find enclosed copies of the Newspaper publication of Postal Ballot Notice of the Company published on 18th November 2025, in Business Standard and Sakal newspapers.
Declaration of Voting Results & Voting Rights Announcements Classification · 90% confidence The document is a letter addressed to stock exchanges regarding the publication of a newspaper notice about a postal ballot for the appointment of a new Director and Managing Director. It references compliance with SEBI regulations and includes newspaper copies as enclosures. The content is an announcement of the notice dissemination rather than the notice itself or the results of voting. There is no detailed financial data, management discussion, or report content. The document is short and serves as an official communication to the exchanges about the publication of a notice for shareholder voting. Therefore, it fits best under the category of Declaration of Voting Results & Voting Rights Announcements (DVA), as it relates to shareholder voting notices and regulatory compliance announcements about voting procedures.
2025-11-18 English
Shareholders meeting
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a Postal Ballot Notice from Sanofi India Limited dated November 2025. It details the process for members to vote electronically on the appointment of a new Director and Managing Director. It includes the voting schedule, legal references to the Companies Act, SEBI regulations, and instructions for remote e-voting. The document is a notice to shareholders to seek approval via postal ballot and remote e-voting, not the results or a report of the voting outcome. It is not a full report or financial statement but a solicitation for shareholder approval on specific resolutions. Therefore, it fits the category of Proxy Solicitation & Information Statement (PSI), which includes materials sent to shareholders to provide information and request votes for meetings or resolutions.
2025-11-17 English
The Notice of Postal Ballot for appointment of Managing Director is enclosed.
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a Postal Ballot Notice from Sanofi India Limited dated November 2025. It details the process for members to vote electronically on the appointment of a new Director and Managing Director. It includes the voting schedule, legal references to the Companies Act, SEBI regulations, and instructions for remote e-voting. The document is a notice seeking shareholder approval via postal ballot, not the results of the vote or a report of the meeting. It is not a full report, financial statement, or management discussion. It is also not a proxy solicitation or voting results announcement but the notice initiating the postal ballot process. Therefore, the document fits the category of Proxy Solicitation & Information Statement (PSI), which covers materials sent to shareholders to provide information and request votes for meetings or resolutions.
2025-11-17 English
Analysts/Institutional Investor Meet/Con. Call Updates
Call Transcript Classification · 100% confidence The document is a transcript of an investor/analyst conference call held by Sanofi India Limited on October 29, 2025. It discusses the company's financial performance for the quarter and nine months ended September 30, 2025, including detailed commentary on revenue, exports, operational expenses, and strategic initiatives. The text includes a Q&A session with investors, which is typical of earnings or investor call transcripts. The document explicitly states it is a transcript of the Investor/Analysts Call and contains detailed spoken content rather than a summary or announcement. Therefore, it fits the category of a Call Transcript (CT).
2025-11-04 English
Please find enclosed transcript of Investor/Analysts call held on 29th October 2025.
Call Transcript Classification · 100% confidence The document is a transcript of an investor/analyst conference call held by Sanofi India Limited on October 29, 2025. It discusses the company's financial results for the quarter and nine months ended September 30, 2025, including detailed commentary on revenue, operational expenses, export impacts, and strategic transformation. The presence of a Q&A session further confirms it is a full transcript of the call. The document references un-audited financial results but does not itself constitute a financial report like an interim or annual report. It is not a brief announcement or a regulatory filing but a detailed call transcript. Therefore, the appropriate classification is Call Transcript (CT).
2025-11-04 English
Record Date
Notice of Dividend Amount Classification · 100% confidence The document is a formal communication addressed to stock exchanges regarding the declaration of an interim dividend and the fixing of a record date for shareholders entitled to receive the dividend. It references Regulation 42 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to dividend record dates. The document does not contain financial statements or detailed financial analysis but is an announcement of dividend-related information. The document length is short (1514 characters), and it is clearly an announcement rather than a full report. Therefore, it fits the category of Notice of Dividend Amount (DIV).
2025-10-31 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.